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CASE REPORT
Fig. 1. Solitary, 10-mm sized, pink-brown, elevated, firm nodule 
with smooth surface on the nasal skin was seen. 
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Hidradenoma papilliferum is a rare benign neoplasm that 
usually occurs in the female anogenital area. We present a 
43-year-old female with a non-anogenital (ectopic) hidrade-
noma papilliferum on her nose. The patient had had a 
skin-colored subcutaneous nodule on her nose for 7 years. 
The histopathological findings showed variously shaped 
cystic spaces in the tumor. And the lumina were surrounded 
by a single or double layer of cell which showed decapitation 
secretion. In the English dermatological literature, only one 
case of ectopic hidradenoma papilliferum arising in nasal 
skin has been reported. Hence we suggest hidradenoma 
papilliferum occurring on the nasal skin is a peculiar and 
interesting event. (Ann Dermatol 23(S2) S254∼S257, 2011)
-Keywords-
Ectopic, Hidradenoma papilliferum, Nose
INTRODUCTION
Hidradenoma papilliferum is a benign, cystic, papillary 
tumor that originates from the apocrine gland or 
anogenital mammary gland; it occurs almost exclusively 
in the female anogenital area
1-4. However, these tumors 
occasionally occur in a non-anogenital area and are 
referred to as "ectopic" hidradenoma papilliferum
1,5-9. 
Ectopic hidradenoma papilliferum usually occurs in the 
head and neck region; most cases of ectopic hidradenoma 
papilliferum occur in the external ear or eyelid, where 
modified apocrine glands are found. Although ectopic 
apocrine glands are found normally in the nose, there has 
been only one case of ectopic hidradenoma papilliferum 
arising in nasal skin
8. The tumor may show a variety of 
histopathological findings including cystic, tubular, 
papillary or solid pattern
2-5. Herein we report a peculiar 
case of ectopic hidradenoma papilliferum on the nose.
CASE REPORT
A 43-year-old female complained of an asymptomatic 
tumor on her nose that had been slowly growing for 7 
years. On physical examination, a 10-mm sized, pink- 
brown, elevated, firm nodule with a smooth surface was 
seen (Fig. 1). 
The clinician's differential diagnosis included intradermal 
nevus, trichoepithelioma, and basal cell carcinoma. The Hidradenoma Papilliferum Occurring on the Nasal Skin
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Fig. 3. Positive reactivity with gross cystic disease fluid protein
is seen (immunoperoxidase, ×40).
Fig. 4. Positive reactivity with epithelial membrane antigen is 
seen (immunoperoxidase, ×40).
Fig. 2. Variously shaped cystic and tubular structures were lined with a double or single layer of inner columnar and outer cuboidal
cells. The cells of the lumina showed decapitation secretion similar to that of apocrine gland (A: H&E, ×40, B: H&E, ×200).
tumor was excised and subjected to histopathological 
examination.
Microscopic examination showed a subcutaneous tumor 
that was well-circumscribed by connective tissue. Vari-
ously shaped cystic and tubular structures were seen. The 
lumina of those cystic structures were lined with a double 
or single layer of inner columnar and outer cuboidal cells. 
The cells of the lumina showed decapitation secretion 
similar to apocrine gland (Fig. 2). The epithelial cells of 
the lesion were strongly positive for gross cystic disease 
fluid protein (Fig. 3) and epithelial membrane antigen 
(EMA) (Fig. 4) but weakly positive for carcinoembryonic 
antigen (CEA) (Fig. 5) on immunoperoxidase examination. 
The lesion was excised, and the patient had no evidence 
of recurrence at 6-month follow-up.
DISCUSSION
Hidradenoma papilliferum is a benign adnexal tumor that 
mainly affects middle-aged women between the ages of 
30 to 49 years (range, 25∼66 years)
10. It usually appears 
as a solitary, well-circumscribed, firm, flesh- to red- 
colored nodule of approximately 0.4 cm in diameter 
(range 0.1∼1.0 cm)
10. The nodule can also be umbili-
cated or cystic, and may be asymptomatic; however, 
bleeding, pain or pruritus can be associated
1-4. Because 
these tumors occur almost exclusively in the vulva or 
perianal region, extragenital hidradenoma papilliferum are 
referred to as "ectopic hidradenoma papilliferum"
9. 
Ectopic hidradenoma papilliferum has been reported in 19 
people in the English dermatological literature
5,6.HJ Lee, et al
S256 Ann Dermatol
Fig. 5. Cytoplasm of these cells is negative for carcinoembryonic
antigen (immunoperoxidase, ×40). 
The clinical manifestations of ectopic hidradenoma papil-
liferum are similar to those of anogenital hidradenoma 
papilliferum. Lesions range in size from 0.5 to 6.0 cm; 
more than 85% of the lesions are about 1.5 cm in size
9. 
The most common site of ectopic hidradenoma 
papilliferum is the head and neck region
6-9. Lesions have 
occurred on the eyelid (3 lesions), forehead (2 lesions), 
face (site unspecified, 2 lesions), external auditory canal (1 
lesion), postauricular area (1 lesion), scalp (1 lesion), and 
nose (1 lesion). Other lesion sites include the axilla, arm, 
thigh and back. Although the reason that most cases of 
hidradenoma papilliferum occur in the head and neck 
region has not been clarified, their location may be related 
to the distribution of apocrine glands. Apocrine glands are 
heavily concentrated in the anogenital area and axillae, 
most cases of hidradenoma papilliferum are located in the 
anogenital area. Modified apocrine glands are normally 
found in the external auditory ear canal, eyelid and breast. 
Thus the location of ectopic hidradenoma papilliferum 
corresponds to these common sites of apocrine glands and 
modified apocrine glands
5-7. In our patient, it is possible 
that the heterotrophic apocrine gland normally found in 
the nasal skin may be related to the development of 
tumor. Therefore, the heterotrophic apocrine gland in the 
resection specimen may be heterotrophic apocrine glands 
adjacent to the tumor in the nasal skin
8.
Histopathologic examination showed solitary, well-cir-
cumscribed, cystic spaces in the dermis surrounded by 
tissue with no connection to the overlying epidermis. 
Within the cystic spaces, multiple papillary projections 
into the cavity were seen. The lumen is usually lined with 
double or multiple rows of columnal cells or simple 
cuboidal cells with active "decapitation" secretion like 
that found in the apocrine gland. Although these inva-
ginations that extend downward from epidermis and 
papillary projections can be found in syringocystadenoma 
papilliferum, the absence of connection in the papillary 
structure distinguishes hidradenoma papilliferum from 
syringocystadenoma papilliferum. Immunohistochemically, 
the hidradenoma papilliferum expresses EMA, CEA, gross 
cystic disease fluid protein (GCDFP)-15 and human milk 
fat globule membrane antigen (HMFG) and are usually 
positive for the markers of apocrine differentiation. 
Syringocystadenoma papilliferum usually express AE1/AE3, 
EMA and CEA, but the results of markers of apocrine 
differentiation including GCDFP-15 and HMFG are 
variable.
Although the exact pathogenesis of hidradenoma papil-
liferum is unclear, the fact that these tumors have only 
been reported after puberty suggests that estrogen receptor 
expression may be involved
9. Regardless of the site and 
size, the treatment of choice is local excision and 
recurrence is unusual. Recently, some authors found 
similarities between hidradenoma papilliferum arising 
from extra-genital area and apocrine papillary cysta-
denoma
11,12. The similarity of histopathology and apocrine 
differentiation in both tumors suggest that they may be 
identical tumors, but further study is needed.
The differential diagnosis includes syringocystadenoma 
papilliferum, tubular apocrine adenoma, and clear cell 
(apocrine) hidradenoma. Syringocystadenoma shows some 
cystic invaginations extending downward from the epi-
dermis as well as plasma cell infiltration. In tubular 
apocrine adenoma, some dilated tubules with papillary 
projections extend into the lumen. In clear cell hidra-
denoma, the lesions are constructed with apocrine-like 
tubular structures and clear cells can be seen
6.
The prognosis for hidradenoma papilliferum is good
1-4. 
Malignant transformation of these tumors is rare and there 
are only 2 reports of carcinoma arising in a pre-existing 
hidradenoma papilliferum
11.
In conclusion, we suggest hidradenoma papilliferum 
occurring on the nasal skin is a peculiar and interesting 
event.
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